Skip to main content

Table 1 Demographic and pathological features of patients

From: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Patients characteristics N = 50 (%)
Median age 47.5 (min-maks; 24–76)
 Premenopausal 23 (46%)
 Postmenopausal 27 (54%)
Family history
 Yes 6 (12%)
 No 44 (88%)
Clinic T
 T1 3 (6%)
 T2 18 (36%)
 T3 7 (14%)
 T4 22 (44 %)
Clinic N
 N0 2 (4 %)
 N1 30 (60 %)
 N2 11 (22 %)
 N3 7 (14 %)
Pathological T
 T1 22 (44%)
 T2 16 (32%)
 T3 9 (18 %)
 T4 3 (6 %)
Pathological N
 N0 17 (34%)
 N1 14 (28%)
 N2 9 (18%)
 N3 10 (20%)
Surgical procedures
 Modified radical mastectomy 31 (62%)
 Mastectomy and SLNB (+) and ALND 5 (10%)
 Mastectomy and SLNB (−) 3 (6%)
 BCS &ALND 3 (6%)
 BCS &SLNB (+) and ALND 4 (8%)
 BCS& SLNB (−) 4 (8%)
Pathological findings
Invasive ductal carcinoma 39 (78%)
Invasive lobular carcinoma 3 (6%)
Metaplastic 6 (12%)
Invasive ductal carcinoma+ invasive lobular carcinoma 1 (2%)
Undifferentiated carcinoma 1 (2%)
  1. BCS breast conserving surgery, SLNB sentinel lymph node biopsy, ALND axillary lymph node dissection